ANNX
AnnexonยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ANNX Profile
Annexon, Inc.
A clinical-stage biopharmaceutical company that develops medicines for classical complement-mediated autoimmune, neurodegenerative and ophthalmic disorders
Biological Technology
03/03/2011
07/24/2020
NASDAQ Stock Exchange
100
12-31
Common stock
1400 Sierra Point Parkway, Bldg C, Suite 200, Brisbane, California 94005
--
Annexon, Inc., was incorporated under the laws of the State of Delaware on March 3, 2011. The company is a clinical-stage biopharmaceutical company developing novel therapies for classical complement-mediated diseases of the body, brain and eyes.
